ASAM serves its members in many ways. One of the most important ways is by helping to play an active role in shaping government policies that affect their livelihoods and the lives of their patients.

ASAM advocates for policies that promote access to high-quality treatment and recovery support services for the 22 million Americans who suffer from a substance use disorder. The information here will help you stay up to date on emerging issues, enable you to take action and become an advocate for your patients and your practice, and learn about how ASAM is working with government, insurers and other national organizations to promote policies that advance addiction medicine.


Opioid misuse and overdose are a public health crisis in the United States.  ASAM and others have come together as the Coalition to Stop Opioid Overdose to advance meaningful legislative and regulatory policies this year in response to the opioid epidemic.

2016 NPF Training_472x176 

2018 NPF Training

Audio, text, slides, photos and selected 5-minute videos segments from the 2018 NPF/ ASAM Training held at the 49th ASAM Annual Conference in San Diego, CA.

Advocacy Toolkits_472x176

Advocacy Toolkits

Access resources that will equip you to advocate effectively for policies that promote addiction treatment and prevention.

Advocacy Events_472x176

Advocacy Issues

Find the latest information on issues of importance to the field of addiction medicine.

NPF training_472x176

Advocacy News

News and information about ASAM Advocacy.

Find a Policy Statement_472x176

Find a Policy Statement

Learn about ASAM's position on current policy issues.


Kelly Corredor
Director, Advocacy and Government Relations | 301.547.4111


Susan Awad
Policy Advisor | 301.547.4103


Corey Barton
Manager, Private Sector Relations | 301.547.4106


Brad Bachman
Manager, State Advocacy and Government Relations | 301.547.4107


Connor Galvin
Specialist, Federal Advocacy and Policy | 301.547.4135

Committee Chairs

Corey Waller, MD, MS, FACEP
Flora Sadri, DO, MPF, FAAFP

Chair and Vice Chair, Legislative Advocacy Committee


Jeffrey Selzer, MD, DFASAM
Randolph Holmes, MD, FASAM

Chair and Vice Chair, Public Policy Committee


Shawn Ryan, MD, MBA, FASAM
Frank James, MD, JD

Chair and Vice Chair, Payer Relations Committee

Advocacy Articles

ASAM Applauds President Trump For Taking Historic Step

by ASAM Staff | Oct 27, 2017

Rockville, MD - Yesterday, President Donald J. Trump directed the declaration of a Nationwide Public Health Emergency to address the country’s opioid crisis. The American Society of Addiction Medicine (ASAM) applauds President Trump for taking this historic step. However, it’s critical for our nation to understand that opioid addiction is a chronic disease that leads to characteristic biological, psychological, and social manifestations, often requiring long-term treatment and support to address these components. As a result, this historic step must remain part of a longer march toward a day when all communities have been empowered to build a healthcare delivery infrastructure that can consistently deliver affordable, evidence-based addiction treatment to those in need. Corey Waller, MD, MS, FACEP, DFASAM,  Chair of ASAM’s Legislative Advocacy Committee, had this to say about the President’s announcement:

“We hope the public health emergency declaration will lay the groundwork for long-term, systemic changes to our prevention and treatment delivery systems, as well as to our training programs for physicians and other health professionals. If we are truly going to turn the tide and prevent future crises related to substance misuse and addiction, then we must come together to make the investments required. ASAM will continue to work closely with the President, his administration, and Congress to broaden access to evidence-based addiction treatment and prevention programs that will profoundly improve the health and safety of all people.”